Advertisement
Screener

KRAIG BIOCRAFT LABORATORIES, INC. (KBLB) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price

KRAIG BIOCRAFT LABORATORIES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price

KRAIG BIOCRAFT LABORATORIES, INC. (KBLB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $0.12 per share for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-01.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2024-04-01

  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2022 was $0.12, a 0.00% change from fiscal 2021.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2021 was $0.12.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month
2022-12-31$0.12
10-K · filed 2024-04-01
2021-12-31$0.12
10-K · filed 2023-03-29